New Clinical Study for Men’s Urinary Incontinence Device
Contino® is a self-administered licensed medical device that helps manage bladder leakage in men. The device has been licensed by Health Canada after the completion of a five-year, multi-site Canadian clinical trial.
We are now enrolling male volunteers with urinary incontinence to participate in a post-market clinical follow-up study for the device.
If eligible to participate, you will be seen by a study doctor and will receive study-related testing and the device at no cost. If enrolled, you may be reimbursed for parking and travel expenses.
You may be eligible if:
- you are male, 18 years of age or older; and
- you have evidence of moderate to severe urinary incontinence
There will be six visits to the study doctor’s office over the course of one year.
To see if you are an eligible candidate for this clinical study, complete the questionnaire using the button below or by visiting myconti.no/study.
You may also: Call the CMX Research Inc. Patient Recruitment Centre at 1-866-666-3329 Email the CMX Research Inc. at firstname.lastname@example.org
To learn about Contino®, visit mycontino.com